DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)
South Korea flag South Korea · Delayed Price · Currency is KRW
16,640
+1,510 (9.98%)
At close: Feb 27, 2026

DAE HWA Pharmaceutical Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
291,477191,632164,306164,657163,255269,902
Market Cap Growth
62.98%16.63%-0.21%0.86%-39.51%21.16%
Enterprise Value
388,817288,813265,142243,200219,445325,800
Last Close Price
16640.0010838.569161.159028.018795.5414370.29
PE Ratio
7337.11360.61-147.5973.63-
PS Ratio
1.951.281.161.251.392.47
PB Ratio
3.952.512.122.021.963.13
P/TBV Ratio
7.454.493.673.272.964.49
P/FCF Ratio
149.51218.93--232.62-
P/OCF Ratio
56.9836.50-20.1015.72101.72
EV/Sales Ratio
2.601.931.881.841.872.98
EV/EBITDA Ratio
32.4822.0233.8523.4127.0833.90
EV/EBIT Ratio
65.9843.03135.1241.6066.8282.64
EV/FCF Ratio
199.44329.96--312.68-
Debt / Equity Ratio
1.361.301.431.100.840.74
Debt / EBITDA Ratio
8.387.5714.118.678.666.61
Debt / FCF Ratio
51.48113.42--99.96-
Net Debt / Equity Ratio
1.251.201.251.000.620.59
Net Debt / EBITDA Ratio
7.726.9712.397.906.385.33
Net Debt / FCF Ratio
47.42104.43-10.64-4.2173.71-45.96
Asset Turnover
0.710.700.680.700.670.64
Inventory Turnover
3.043.353.864.103.853.63
Quick Ratio
0.260.250.290.330.490.39
Current Ratio
0.530.520.510.620.750.66
Return on Equity (ROE)
0.52%1.08%-0.65%1.48%2.31%-2.92%
Return on Assets (ROA)
1.74%1.97%0.59%1.94%1.17%1.44%
Return on Invested Capital (ROIC)
0.93%2.15%1.16%1.97%1.04%3.02%
Return on Capital Employed (ROCE)
6.90%7.60%2.20%5.00%3.20%4.00%
Earnings Yield
0.01%0.28%-0.70%0.68%1.36%-0.74%
FCF Yield
0.67%0.46%-5.55%-11.84%0.43%-0.41%
Dividend Yield
0.90%1.38%1.64%1.66%--
Payout Ratio
6613.98%494.43%-235.51%118.28%-
Buyback Yield / Dilution
0.06%---0.33%-0.87%1.48%
Total Shareholder Return
0.96%1.38%1.64%1.34%-0.87%1.48%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.